Must reads

• A July 24, 2014 Denver Post article reported on the efforts of researchers at Colorado University to tackle Alzheimer's. According to the article, "Amid a firehose-stream of bad news about failed Alzheimer's drug trials, Potter's work at CU Hospital with co-investigator Dr. Jonathan Woodcock could provide a breakthrough. The hospital recently received approval to begin safety trials of a drug, Leukine, in Alzheimer's patients. If funding comes through, clinical trials with several hundred patients could follow. Alzheimer's — a debilitating and ultimately fatal brain disease that is the sixth leading cause of death in the U.S. — is incurable."
• A July 23, 2014 Forbes opinion piece by Howard Gleckman, fellow at the Urban Institute, underscored the long road ahead to finding a cure for Alzheimer's. According to Gleckman, "In the meantime, let’s acknowledge the painful reality: We are making only slow, incremental progress in the war against Alzheimer’s and other dementias. We are far from prevention or cure. For now, we should increase our focus on living with dementia and caring for those with this condition."
• A July 23, 2014 Coloradoan article profiled Alan Arnette's K2 climb to raise awareness of Alzheimer's. According to the article, "When news broke Wednesday morning of Pat Bowlen's ongoing battle with Alzheimer's, across the world, on the steep slopes of the world's second-deadliest mountain, a Fort Collins mountaineer rested after a hard day of climbing. Wednesday morning, Alan Arnette released an audio dispatch from Camp 1 on K2, 19,900 feet in the sky. At the end of the dispatch, Arnette, a 57-year-old climber, closed with his trademark, saying: "Climb on.""